Endothelial Cell Hypertrophy and Microvascular Proliferation in Meningiomas Are Correlated with Higher Histological Grade and Shorter Progression-Free Survival

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma

(2016) Kent C. Shih et al.   JOURNAL OF NEURO-ONCOLOGY

CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas

(2016) Xiangyi Kong et al.   MOLECULAR NEUROBIOLOGY

A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer

(2015) Fatima H. Karzai et al.   BJU INTERNATIONAL

Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539

(2015) C. Leland Rogers et al.   NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

(2015) Quinn T. Ostrom et al.   NEURO-ONCOLOGY

An Open-Label Phase Ib Dose-Escalation Study of TRC105 (Anti-Endoglin Antibody) with Bevacizumab in Patients with Advanced Cancer

(2014) M. S. Gordon et al.   CLINICAL CANCER RESEARCH

Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients

(2013) Fabio P. Nunes et al.   PLoS One

CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34

(2013) Yasuyoshi Miyata et al.   VIRCHOWS ARCHIV

Preoperative Particle and Glue Embolization of Meningiomas

(2013) Anouk Borg et al.   Operative Neurosurgery

Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches

(2012) Matthias Preusser et al.   CLINICAL NEUROPATHOLOGY

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

(2012) Emil Lou et al.   JOURNAL OF NEURO-ONCOLOGY

Atypical and anaplastic meningiomas treated with bevacizumab

(2012) Lakshmi Nayak et al.   JOURNAL OF NEURO-ONCOLOGY

Predicting Outcomes of Patients With Intracranial Meningiomas Using Molecular Markers of Hypoxia, Vascularity, and Proliferation

(2012) Randy Jensen et al.   NEUROSURGERY

Opportunities for clinical research in meningioma

(2010) Michael A. Vogelbaum et al.   JOURNAL OF NEURO-ONCOLOGY

Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas

(2008) Nicky D’Haene et al.   BRITISH JOURNAL OF HAEMATOLOGY

Therapeutic embolization of meningiomas with Onyx for delayed surgical resection

(2008) Zhong-Song Shi et al.   SURGICAL NEUROLOGY